FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

327026002: Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    466696015 Irinotecan hydrochloride trihydrate 100mg/5mL infusion concentrate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1457174013 Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1477702016 Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial Is a Irinotecan hydrochloride false Inferred relationship Some
    Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial Is a Product containing irinotecan (medicinal product) false Inferred relationship Some
    Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial Is a Irinotecan hydrochloride false Inferred relationship Some
    Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Irinotecan hydrochloride (substance) false Inferred relationship Some
    Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial Has manufactured dose form injection false Inferred relationship Some
    Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Irinotecan (substance) false Inferred relationship Some
    Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Irinotecan hydrochloride (substance) false Inferred relationship Some
    Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial Is a Product manufactured as parenteral dose form (product) false Inferred relationship Some
    Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial Has manufactured dose form Infusion concentrate false Inferred relationship Some
    Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial Is a Product containing irinotecan in parenteral dose form (medicinal product form) false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Camptosar 20mg/ml injection 5mL vial Is a False Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    Description inactivation indicator reference set

    GB English

    US English

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start